Services and Resources

As an independent company, CIRDR can interface directly with both industry and academia. We have the expertise and resources needed to conduct pharmaceutical-based clinical trials efficiently.

Start-up time for a clinical trial at an academic institution ranges from 4-6 months, and quality of the team dedicated to the project varies widely. At CIRDR, start-up time is 2-6 weeks, and our team is uniformly trained with state-of-the art research resources, and well-developed standard operating procedures for pediatric clinical research.

While resources at academic institutions are often dependent on the experts within the department, the cofounders of CIRDR have collaborators throughout academia to support specialized research and development for pharmaceutical companies and foundations.

The investigators at CIRDR have independently designed and carried out clinical trials in rare disease, and served as principal investigators on a number of pharma-sponsored studies. Additionally, CIRDR is part of a multi-site study bringing together 10 investigators, 7 coordinators, and 6 post-docs and assistants from 5 institutions around the country. The departments involved include both pediatric and adult neurology, neuropsychology, sleep medicine, genetics, biomedical engineering, and cell biology. We collaborate with both device manufacturers in industry  and biomedical engineers in academia to develop new biotech which could improve detection of physiological changes in clinical trials.